|
 |
| ERRATUM |
|
| Year : 2021 | Volume
: 12
| Issue : 4 | Page : 435 |
|
|
Erratum: In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor
| Date of Web Publication | 20-Oct-2021 |
Correspondence Address:
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2231-4040.328640
How to cite this article:
. Erratum: In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor. J Adv Pharm Technol Res 2021;12:435 |
How to cite this URL:
. Erratum: In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor. J Adv Pharm Technol Res [serial online] 2021 [cited 2023 Mar 27];12:435. Available from: https://www.japtr.org/text.asp?2021/12/4/435/328640 |
In the article titled “In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor”, published on pages 261-266, Issue 3, Volume 12 of Journal of Advanced Pharmaceutical Technology & Research,[1] the list of authors is incorrectly written as Putu Gita Maya, Widyaswari Mahayasih, Harizal, Herman, Islamudin Ahmad. The correct list of authors and their affiliation should read as below:
Putu Gita Maya Widyaswari Mahayasih1, Harizal1, Herman2, Islamudin Ahmad3
1Department of Pharmacy, Faculty of Health Sciences, Universitas Esa Unggul, West Jakarta, DKI Jakarta, Indonesia
2Laboratory of Pharmaceutical Research and Development of FARMAKA TROPIS, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, Indonesia
3Department of Pharmaceutical Sciences, Faculty of Pharmacy, Universitas Mulawarman, Samarinda, East Kalimantan, Indonesia
The “How to cite this article” section should read correctly as “Mahayasih PG, Harizal, Herman, Ahmad I. In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor. J Adv Pharm Technol Res 2021;12:261-6”.
| References | |  |
| 1. | Maya PG, Mahayasih W, Harizal, Herman, Ahmad I. In silico identification of natural products from Centella asiatica as severe acute respiratory syndrome-coronavirus 2 main protease inhibitor. J Adv Pharm Technol Res 2021;12:261-6.  [Full text] |
|
